Previous Close | 13.98 |
1-Year Change | -34.52% |
6-Months Change | -38.2% |
3-Months Change | -27.19% |
Moving Avg (50d) | 17.748 |
Moving Avg (200d) | 22.206 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.26B |
Beta (3-Years) | 1.87 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -42.2% |
EPS (ttm) | -3.19 |
PE Ratio (ttm) | -4.38 |
Dividend Yield | % |
Asset Description: | Rocket Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-10-23 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
13.301 | 13.692 | 13.953 | 14.344 | 14.996 | 15.648 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |